Twitxy Saved

Krish Patel

@KrishPatelMD

Executive Director Hematologic Cancer Research @SarahCannonDocs @SCRIOncology #Duke alum. Tweets my own, not medical advice. #cll #lymsm
Nashville, TN Joined November 2013
322 Following 962 Followers 400 Posts

Latest posts 5

Krish Patel @KrishPatelMD
Looking forward to a really engaging EHA and then post EHA discussion on lots of amazing new data to highlight in hematology! @SarahCannonDocs @SCRIOncology

#lymsm #heme #EHA2026 #research
VJHemOnc Verified account @VJHemOnc Jun 1
REGISTER for our Post-EHA 2026 Highlights ๐Ÿฉธ

Webinar series by VJHemOnc featuring presentations & discussions on selected abstracts from the 31st Congress of the European Hematology Association (EHA)

๐Ÿ“ Webinar series
๐Ÿ—“๏ธ 23 June-2nd July 2026

Covering:
๐Ÿ“Œ Lymphoma - Chaired by: @KrishPatelMD
๐Ÿ“Œ MPNs - Chaired by: @harrisoncn1
๐Ÿ“Œ AML - Chaired by: @Daver_Leukemia
๐Ÿ“Œ Myeloma - Chaired by: Dr Karthik Ramasamy
๐Ÿ“Œ MDS - Chaired by: @Dr_AmerZeidan
๐Ÿ“Œ CLL - Chaired by: Dr Alexey Danilov

Agendas coming soon! ๐Ÿ‘€

Secure your spot ๐Ÿ”— ๐Ÿ‘‰ vjhemonc.com/event/post-ehaโ€ฆ
View quoted post on X
Krish Patel @KrishPatelMD
Excited to join a stellar crew of faculty in Nashville for this exciting meeting!
Nashville Hematology Conference Verified account @NashvilleHeme Feb 9
Excited to highlight faculty member Dr. @KrishPatelMD, Director of Lymphoma Research at Sarah Cannon Research Institute and expert medical oncologist at SCRI Oncology Partners in Nashville! With his focus on novel therapeutics, cellular therapies, and clinical trials for lymphomas and CLL, he's delivering game-changing insights to #NashvilleHeme26. FREE registration is still open for this 2-day CE-accredited conference, Feb 26-28, 2026. Secure your spot with code FREECME and join over 60 top experts: na2.hubs.ly/H03qYDn0 #Hematology #CME
View quoted post on X
Krish Patel @KrishPatelMD
Incredible work by one of the best, congrats @niravshahmd !
Nirav Shah @niravshahmd Nov 21, 2024
Now two multicenter studies with this construct in Europe (2nd line DLBCL) and US (3rd line DLBCL). Thanks to all the people who helped along the way @MCWCancerCenter @MediHumdani @timfenske @Phari among others. Hope to one day see this product approved for pts across the world!
View quoted post on X